Literature DB >> 35948434

Role of Ubiquilin-2 in Proteostasis and Tau Aggregation in Tauopathies.

Yuxing Xia1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35948434      PMCID: PMC9374129          DOI: 10.1523/JNEUROSCI.0839-22.2022

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.709


× No keyword cloud information.
  20 in total

1.  Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.

Authors:  Cara Rothenberg; Deepa Srinivasan; Leann Mah; Susmita Kaushik; Corrine M Peterhoff; Janet Ugolino; Shengyun Fang; Ana Maria Cuervo; Ralph A Nixon; Mervyn J Monteiro
Journal:  Hum Mol Genet       Date:  2010-06-07       Impact factor: 6.150

Review 2.  Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease.

Authors:  Fang-Lin Weng; Ling He
Journal:  Neurobiol Aging       Date:  2020-12-08       Impact factor: 4.673

Review 3.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

4.  Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradation.

Authors:  Yuxing Xia; Linda H Yan; Bo Huang; Mujun Liu; Xionghao Liu; Cao Huang
Journal:  J Neurochem       Date:  2013-11-22       Impact factor: 5.372

Review 5.  Tau in physiology and pathology.

Authors:  Yipeng Wang; Eckhard Mandelkow
Journal:  Nat Rev Neurosci       Date:  2015-12-03       Impact factor: 34.870

Review 6.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

Authors:  Diane P Hanger; Brian H Anderton; Wendy Noble
Journal:  Trends Mol Med       Date:  2009-02-24       Impact factor: 11.951

7.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.

Authors:  Han-Xiang Deng; Wenjie Chen; Seong-Tshool Hong; Kym M Boycott; George H Gorrie; Nailah Siddique; Yi Yang; Faisal Fecto; Yong Shi; Hong Zhai; Hujun Jiang; Makito Hirano; Evadnie Rampersaud; Gerard H Jansen; Sandra Donkervoort; Eileen H Bigio; Benjamin R Brooks; Kaouther Ajroud; Robert L Sufit; Jonathan L Haines; Enrico Mugnaini; Margaret A Pericak-Vance; Teepu Siddique
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

Review 8.  Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system.

Authors:  Min Jae Lee; Jung Hoon Lee; David C Rubinsztein
Journal:  Prog Neurobiol       Date:  2013-03-23       Impact factor: 11.685

9.  Tau phosphorylation affects its axonal transport and degradation.

Authors:  Teresa Rodríguez-Martín; Inmaculada Cuchillo-Ibáñez; Wendy Noble; Fanon Nyenya; Brian H Anderton; Diane P Hanger
Journal:  Neurobiol Aging       Date:  2013-04-17       Impact factor: 4.673

Review 10.  Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy.

Authors:  Shanya Jiang; Kiran Bhaskar
Journal:  Front Mol Neurosci       Date:  2020-10-16       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.